T1	Participants 49 69	peptic ulcer disease
T2	Participants 118 144	European multicentre trial
T3	Participants 85 104	Dutch investigation
T4	Participants 232 313	230 patients with endoscopically documented gastric (71) or duodenal (159) ulcers
